Apidra

DRUG4 trials

Sponsors

University of Florida, Centre Hospitalier Universitaire Dijon, Kinderkrankenhaus auf der Bult, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Conditions

LipoatrophyPatient With Type 2 Diabetes Treated With Insulin Using a Baseline/Bolus StrategyType 1 DiabetesType 1 Diabetes Mellitus

Phase 4

Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes

TerminatedNCT02048189

Centre Hospitalier Universitaire DijonPatient With Type 2 Diabetes Treated With Insulin Using a Baseline/Bolus Strategy

Start: 2012-03-08Updated: 2024-02-21

Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)

CompletedNCT02914886

Kinderkrankenhaus auf der BultLipoatrophy, Type 1 Diabetes

Start: 2016-09-30End: 2019-04-30Updated: 2024-10-15

Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)

CompletedNCT03328845

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludType 1 Diabetes Mellitus

Start: 2017-01-20End: 2021-11-20Updated: 2021-12-06

Unknown Phase

Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia

CompletedNCT01621776

University of FloridaType 1 Diabetes

Start: 2011-06-30End: 2012-08-31Updated: 2013-09-13